Augmentation of SSRI treatment

Augmentation of SSRI treatment

Dettagli Bibliografici
Autore principale:	Cowen, P
Natura:	Journal article
Pubblicazione:	2008

Documenti analoghi

SSRI treatment decreases prolactin and hyperthermic responses to mCPP.
di: Quested, D, et al.
Pubblicazione: (1997)

Short-term SSRI treatment remediates amygdala hyperactivity in depressed patients
di: Godlewska, B, et al.
Pubblicazione: (2011)

Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.
di: Godlewska, B, et al.
Pubblicazione: (2012)

Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission.
di: Cowen, P, et al.
Pubblicazione: (1997)

Neural response to implicit emotions as biomarkers of clinical response to SSRI treatment in depression
di: Godlewska, B, et al.
Pubblicazione: (2017)

Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression
di: Godlewska, B, et al.
Pubblicazione: (2016)

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.
di: Harmer, C, et al.
Pubblicazione: (2013)

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression.
di: Harmer, C, et al.
Pubblicazione: (2013)

Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.
di: Bhagwagar, Z, et al.
Pubblicazione: (2004)

SHORT-TERM SSRI TREATMENT REMEDIATES AMYGDALA HYPERACTIVITY IN DEPRESSED PATIENTS: A PLACEBO-CONTROLLED STUDY
di: Godlewska, B, et al.
Pubblicazione: (2011)

Does tryptophan supplementation induce similar changes in emotional processing to an SSRI?
di: Murphy, SE, et al.
Pubblicazione: (2005)

SSRI-induced hyponatremia
di: Archana Javadekar, et al.
Pubblicazione: (2014-01-01)

Post-SSRI sexual dysfunction and SSRI induced sexual dysfunction - literature review
di: Eliasz Panek, et al.
Pubblicazione: (2023-04-01)

Differences between SSRI and SNRI in depression treatment
di: Mateusz Grego, et al.
Pubblicazione: (2025-01-01)

Acute SSRI administration affects the processing of social cues in healthy volunteers.
di: Harmer, C, et al.
Pubblicazione: (2003)

Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.
di: Sharpley, A, et al.
Pubblicazione: (2005)

The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action
di: Murphy, SE, et al.
Pubblicazione: (2021)

Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration
di: Vai, B, et al.
Pubblicazione: (2016)

SSRI Facilitated Crack Dancing
di: Ravi Doobay, et al.
Pubblicazione: (2017-01-01)

Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing
di: Murphy, S, et al.
Pubblicazione: (2008)

Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
di: Boothman, L, et al.
Pubblicazione: (2006)

Decreased neural response to fear after a short-term SSRI treatment: a 3T functional magnetic resonance imaging study
di: Godlewska, B, et al.
Pubblicazione: (2011)

Using pharmacological fMRI to examine the effect of an SSRI on the neural circuitry underpinning threat processing
di: Murphy, SE, et al.
Pubblicazione: (2008)

SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex
di: McCabe, C, et al.
Pubblicazione: (2011)

SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex.
di: McCabe, C, et al.
Pubblicazione: (2011)

Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment
di: Åsa Edvinsson, et al.
Pubblicazione: (2020-01-01)

Stimulant and SSRI Medication Trends in ADHD
di: J Gordon Millichap
Pubblicazione: (2001-06-01)

THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) AS TREATMENT OF DEPRESSION IN PATIENTS WITH EPILEPSY
di: Yu. V. Solomatin, et al.
Pubblicazione: (2016-12-01)

Effects of SSRI treatment on GABA and glutamate levels in an associative relearning paradigm
di: B. Spurny, et al.
Pubblicazione: (2021-05-01)

Ssri-treated psychiatric disorders prediction with AI
di: A. Mereu
Pubblicazione: (2021-04-01)

Serotonin Syndrome Due to Overdose Intake of SSRI
di: Yavuz Orak, et al.
Pubblicazione: (2015-08-01)

SSRI use in pregnancy: Evaluating the risks and benefits
di: Elsa du Toit, et al.
Pubblicazione: (2015-05-01)

A Case of SSRI Induced Irreversible Parkinsonism
di: Siddharth Dixit, et al.
Pubblicazione: (2015-02-01)

Profiling placental DNA methylation associated with maternal SSRI treatment during pregnancy
di: Amy M. Inkster, et al.
Pubblicazione: (2022-12-01)

SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli
di: Antonia Preuss, et al.
Pubblicazione: (2020-11-01)

Clinico-biochemical Study of the Safety and Tolerability of Selective Serotonin Reuptake Inhibitors (SSRI) with Special Reference to SSRI Induced Hyponatremia in Humans and Animals
di: Suhena Sarkar, et al.
Pubblicazione: (2021-03-01)

Investigation of the behavioural and neurobiological effects of SSRI discontinuation in mice
di: Collins, HM
Pubblicazione: (2023)

SSRI induced hypnic jerks: A case series
di: Rakesh Kumar, et al.
Pubblicazione: (2023-07-01)

LONGTERM OFF-LABEL USE OF SSRI IN TREATMENT OF EARLY EJACULATION: TWO CASES REPORT
di: E. Becirovic, et al.
Pubblicazione: (2023-03-01)

Low-Dose Quetiapine in the Treatment of SSRI-Induced Bruxism and Mandibular Dystonia: Case Series
di: Atefeh zandifar, et al.
Pubblicazione: (2018-06-01)